BMRN
Biomarin Pharmaceutical Inc
57.20$
-2.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +1.2% | +0.5% | +2.8% | -3.1% | +2.0% | +2.3% | +4.3% | +2.1% | -0.3% | +13.1% | +36.5% | |
| – | +0.0% | +1.0% | +9.2% | -6.2% | +5.8% | +7.3% | +9.7% | +1.3% | +2.6% | +16.5% | -13.8% | |
| – | -3.9% | -1.1% | +30.1% | -30.5% | +39.6% | +11.2% | +15.7% | +3.0% | +4.9% | +69.4% | -60.7% | |
| – | -4.6% | -2.5% | +17.0% | -24.0% | +22.3% | +11.8% | +12.6% | +3.2% | +5.6% | +42.4% | -60.7% | |
| – | +10.7% | +0.5% | +8.5% | +12.5% | -15.0% | +11.9% | +15.8% | -7.7% | +14.9% | -0.5% | +17.4% | |
| – | +7.3% | +2.8% | +4.0% | -0.4% | +4.5% | +3.4% | +5.1% | +3.1% | -6.0% | -2.0% | +40.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +234.2% | |
| – | -2.6% | -5.1% | -5.0% | -1.7% | -2.2% | -3.1% | -3.1% | -2.7% | -8.3% | -4.3% | +2,284.1% | |
| – | +1.5% | -4.8% | -1.0% | -19.3% | -7.4% | +1.7% | +5.6% | +9.0% | -3.3% | +57.9% | +127.1% | |
| – | +1.2% | -7.6% | -1.9% | -32.9% | -15.2% | +3.5% | +8.9% | +16.7% | -4.9% | +4.5% | +109.8% | |
| – | 0.0% | +0.1% | +0.5% | -98.4% | -6.0% | -16.7% | +22.1% | -1.6% | +14.6% | +7.3% | +7,135.3% | |
| – | +4.7% | -7.4% | -11.9% | +21.3% | -24.6% | +24.8% | +5.8% | +25.4% | -19.7% | +26.4% | +2.9% | |
| – | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +139.5% | +146.7% | |
| – | +1.1% | +2.5% | +4.2% | +2.4% | +4.5% | +2.4% | +4.0% | +0.5% | +0.5% | +2.1% | +1.8% | |
| – | – | – | – | – | – | – | – | -13.3% | -23.2% | +68.4% | +17.2% | |
| – | +0.3% | +3.9% | +0.6% | -1.7% | -0.3% | -0.1% | +0.1% | -2.3% | +2.8% | +0.1% | -1.8% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.